We’re All Becoming Distracted Victims of Smartphones
Your phone buzzes at work. You promised yourself you wouldn’t check your phone until you turn in your half-finished assignment that’s due in an hour, so you don’t. But you start to wonder — who is texting you? What does the text say? Your mind wanders.
A new study has found that even when we try to disregard a notification, just being aware of a new message distracts us enough to impair our concentration and hurt our performance. These distractions are equal to actively opening the notification on your mobile device.
A Gallup poll reveals that 81 percent of smartphone users keep their phone in close proximity “almost all the time during waking hours.” Depending on the volume of notifications users receive, keeping a phone so close could lead to a noticeably negative impact on work performance.
Related: The New Workplace Trend — Smartphone Mini-Vacations
The study adds to the growing list of negative affects smartphones can have on users. Other effects include impaired sleep, increased pressure to communicate with friends and family, and the inability to detach from work.
Smartphones are only going to affect more and more individuals. The number of people who own a smartphone has increased from 35 percent in 2011 to 64 percent in April of this year. Among millennials, 84 percent report owning a smartphone.
As millennials begin to enter the workforce and the number of apps available for download increases, the potential for distraction only grows larger.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
